Obesity Medicine

Latest News

More Than One-Third of Middle-Aged Adults with Diabetes Prescribed GLP-1 RAs: Daily Dose / image credit: ©New Africa/AdobeStock
More Than One-Third of Middle-Aged Adults with Diabetes Prescribed GLP-1 RAs: Daily Dose

September 1st 2025

Your daily dose of the clinical news you may have missed.

Generic Liraglutide Approved, Marking First Generic GLP-1 RA Indicated Specifically for Weight Management in the US / image credit generic autoinjectors ©Kassandra/stock.adobe.com
Generic Liraglutide Approved, Marking First Generic GLP-1 RA Indicated Specifically for Weight Management in the US

August 29th 2025

One in Ten Individuals Initiate GLP-1 Therapy Within 5 Years of Bariatric Surgery, Study Finds
One in Ten Individuals Initiate GLP-1 Therapy Within 5 Years of Bariatric Surgery, Study Finds

August 28th 2025

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

August 26th 2025

What Do Individuals With Obesity Want in am "Ideal" Primary Care Visit? image credit ©Coloures-Pic/stock.adobe.com
What Do Individuals With Obesity Want in an "Ideal" Primary Care Visit?

August 26th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.